Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice

Hypertension

Volumn 55, Issue 5, 2010, Pages 1157-1164

  Wakui, Hiromichi ^a   Tamura, Kouichi ^a   Tanaka, Yutaka ^a   Matsuda, Miyuki ^a   Bai, Yunzhe ^a   Dejima, Toru ^a   Masuda, Shin Ichiro ^c   Shigenaga, Atsu Ichiro ^a   Maeda, Akinobu ^a   Mogi, Masaki ^b   Ichihara, Naoaki ^a   Kobayashi, Yusuke ^a   Hirawa, Nobuhito ^a   Ishigami, Tomoaki ^a   Toya, Yoshiyuki ^a   Yabana, MacHiko ^a   Horiuchi, Masatsugu ^b   Minamisawa, Susumu ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c WASEDA UNIVERSITY   (Japan)

Author keywords

Angiotensin receptors; Basic science; Gene expression regulation; Hypertrophy remodeling; Receptors

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ASSOCIATED PROTEIN; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN HEAVY CHAIN ALPHA; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERTENSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CARDIOMEGALY; GENOTYPE; HEART RATE; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TETRAZOLES;

EID: 77951499906     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.147207     Document Type: Article

References (36)

1. Miura S, Saku K, Karnik SS. Molecular analysis of the structure and function of the angiotensin II type 1 receptor. Hypertens Res. 2003;26: 937-943. (Pubitemid 38128765)
2. Hein L, Meinel L, Pratt RE, Dzau VJ, Kobilka BK. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol. 1997;11: 1266-1277. (Pubitemid 28041334)
3. Daviet L, Lehtonen JY, Tamura K, Griese DP, Horiuchi M, Dzau VJ. Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem. 1999;274: 17058-17062. (Pubitemid 129519035)
4. Lopez-Ilasaca M, Liu X, Tamura K, Dzau VJ. The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell. 2003;14: 5038-5050. (Pubitemid 37484817)
5. Tamura K, Tanaka Y, Tsurumi Y, Azuma K, Shigenaga A, Wakui H, Masuda S, Matsuda M. The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function. Curr Hypertens Rep. 2007;9:121-127. (Pubitemid 46779376)
6. Mogi M, Iwai M, Horiuchi M. Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler Thromb Vasc Biol. 2007;27:2532-2539. (Pubitemid 350158902)
7. Tsurumi Y, Tamura K, Tanaka Y, Koide Y, Sakai M, Yabana M, Noda Y, Hashimoto T, Kihara M, Hirawa N, Toya Y, Kiuchi Y, Iwai M, Horiuchi M, Umemura S. Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules. Kidney Int. 2006;69:488-494. (Pubitemid 43164440)
8. Tanaka Y, Tamura K, Koide Y, Sakai M, Tsurumi Y, Noda Y, Umemura M, Ishigami T, Uchino K, Kimura K, Horiuchi M, Umemura S. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP down-regulates AT1R and ameliorates cardiomyocyte hypertrophy. FEBS Lett. 2005;579:1579-1586. (Pubitemid 40341526)
9. Azuma K, Tamura K, Shigenaga A, Wakui H, Masuda S, Tsurumi-Ikeya Y, Tanaka Y, Sakai M, Matsuda M, Hashimoto T, Ishigami T, Lopez-Ilasaca M, Umemura S. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. Hypertension. 2007;50:926-932. (Pubitemid 350287536)
10. Yuan Z, Nimata M, Okabe TA, Shioji K, Hasegawa K, Kita T, Kishimoto C. Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure. Am J Physiol Heart Circ Physiol. 2005;289:H1147-H1152. (Pubitemid 41208958)
11. Sakai M, Tamura K, Tsurumi Y, Tanaka Y, Koide Y, Matsuda M, Ishigami T, Yabana M, Tokita Y, Hiroi Y, Komuro I, Umemura S. Expression of MAK-V/Hunk in renal distal tubules and its possible involvement in proliferative suppression. Am J Physiol Renal Physiol. 2007;292:F1526-F1536. (Pubitemid 46701880)
12. Shimura M, Minamisawa S, Yokoyama U, Umemura S, Ishikawa Y. Mechanical stress-dependent transcriptional regulation of sarcolipin gene in the rodent atrium. Biochem Biophys Res Commun. 2005;334:861-866. (Pubitemid 41033200)
13. Yoshida M, Minamisawa S, Shimura M, Komazaki S, Kume H, Zhang M, Matsumura K, Nishi M, Saito M, Saeki Y, Ishikawa Y, Yanagisawa T, Takeshima H. Impaired Ca2+ store functions in skeletal and cardiac muscle cells from sarcalumenin-deficient mice. J Biol Chem. 2005;280: 3500-3506. (Pubitemid 40223815)
14. Mills PA, Huetteman DA, Brockway BP, Zwiers LM, Gelsema AJ, Schwartz RS, Kramer K. A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J Appl Physiol. 2000;88:1537-1544. (Pubitemid 30336898)
15. Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn GW II, Ross J Jr, Chien KR, Brown JH. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest. 1999;103:1627-1634. (Pubitemid 29534356)
16. Kato M, Egashira K, Takeshita A. Cardiac angiotensin II receptors are downregulated by chronic angiotensin II infusion in rats. Jpn J Pharmacol. 2000;84:75-77.
17. Tambascia RC, Fonseca PM, Corat PD, Moreno H Jr, Saad MJ, Franchini KG. Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats. Hypertension. 2001;37:1423-1428. (Pubitemid 34225386)
18. Hu C, Dandapat A, Sun L, Marwali MR, Inoue N, Sugawara F, Inoue K, Kawase Y, Jishage K, Suzuki H, Hermonat PL, Sawamura T, Mehta JL. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension. 2008;52:556-562.
19. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J. Tissue-specific regulation of the a-myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 1991;266:24613-24620. (Pubitemid 21908985)
20. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341:1276-1283. (Pubitemid 29489744)
21. Yamazaki T, Komuro I, Yazaki Y. Signalling pathways for cardiac hypertrophy. Cell Signal. 1998;10:693-698. (Pubitemid 28520021)
22. Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, Iwao H. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res. 2003;93:874-883. (Pubitemid 37363062)
23. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54: 227-241.
24. Hein L, Stevens ME, Barsh GS, Pratt RE, Kobilka BK, Dzau VJ. Over-expression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci USA. 1997;94:6391-6396. (Pubitemid 27270695)
25. Paradis P, Dali-Youcef N, Paradis FW, Thibault G, Nemer M. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci USA. 2000; 97:931-936. (Pubitemid 30070412)
26. Zhai P, Yamamoto M, Galeotti J, Liu J, Masurekar M, Thaisz J, Irie K, Holle E, Yu X, Kupershmidt S, Roden DM, Wagner T, Yatani A, Vatner DE, Vatner SF, Sadoshima J. Cardiac-specific overexpression of AT1 receptor mutant lacking G aq/G cri coupling causes hypertrophy and bradycardia in transgenic mice. J Clin Invest. 2005;115:3045-3056. (Pubitemid 41567570)
27. Frank D, Kuhn C, van Eickels M, Gehring D, Hanselmann C, Lippl S, Will R, Katus HA, Frey N. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy. Circulation. 2007;116:2587-2596. (Pubitemid 350179222)
28. Hunyady L, Bor M, Balla T, Catt KJ. Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. J Biol Chem. 1994;269:31378-31382. (Pubitemid 24379489)
29. Tang H, Guo DF, Porter JP, Wanaka Y, Inagami T. Role of cytoplasmic tail of the type 1A angiotensin II receptor in agonist-and phorbol ester-induced desensitization. Circ Res. 1998;82:523-531. (Pubitemid 28129022)
30. Shigenaga A, Tamura K, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Ozawa M, Mogi M, Matsuda M, Uchino K, Kimura K, Horiuchi M, Umemura S. Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule. Hypertension. 2008;52:672-678.
31. Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. J Cardiovasc Pharmacol. 2007;49:362-368. (Pubitemid 47000310)
32. Park JK, Fischer R, Dechend R, Shagdarsuren E, Gapeljuk A, Wellner M, Meiners S, Gratze P, Al-Saadi N, Feldt S, Fiebeler A, Madwed JB, Schirdewan A, Haller H, Luft FC, Muller DN. p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension. 2007;49:481-489. (Pubitemid 46263231)
33. Harada K, Komuro I, Shiojima I, Hayashi D, Kudoh S, Mizuno T, Kijima K, Matsubara H, Sugaya T, Murakami K, Yazaki Y. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation. 1998;97:1952-1959. (Pubitemid 28222190)
34. Kudoh S, Komuro I, Hiroi Y, Zou Y, Harada K, Sugaya T, Takekoshi N, Murakami K, Kadowaki T, Yazaki Y. Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice. J Biol Chem. 1998;273:24037-24043. (Pubitemid 28435745)
35. van Kats JP, Methot D, Paradis P, Silversides DW, Reudelhuber TL. Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice: direct and indirect effects of angiotensin II on the heart. J Biol Chem. 2001;276:44012-44017. (Pubitemid 37383971)
36. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA. 2006;103:17985-17990. (Pubitemid 44852272)